Liver damage induced by bile duct ligation affects CYP isoenzymes differently in rats

Pharmacology and Toxicology

Volumn 82, Issue 2, 1998, Pages 89-92

  Tateishi, Tomonori ^a   Watanabe, Minoru ^a   Nakura, Hironori ^a   Tanaka, Masami ^a   Kumai, Toshio ^a   Kobayashi, Shinichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ETHOXYRESORUFIN DEETHYLASE; ISOENZYME; OXYGENASE; STEROID MONOOXYGENASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; ENZYME ACTIVITY; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT;

ANIMALIA;

EID: 0031882873     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01403.x     Document Type: Article

References (19)

1. Babany, G., V. Descatoire, M. Corbic, et al.: Regulation of renal cytochrome P-450. Effects of two-thirds hepatectomy, cholestasis, biliary cirrhosis and post-necrotic cirrhosis on hepatic and renal microsomal enzymes. Biochem. Pharmacol. 1985, 34, 311-320.
2. Butner, J. T. M., T. Zysset & J. Reichen: Metabolism of antipyrine in vivo in two rat models of liver cirrhosis. Its relationship to intrinsic clearance in vitro and microsomal membrane lipid composition. Biochem. Pharmacol. 1993, 46, 983-991.
3. Chen, J., M. Murray, C. Liddle, X.-M. Jiang & G. C. Farrell: Down-regulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats: importance to reduced hepatic content of cytochrome P450 in cholestasis. Hepatology 1995, 22, 580-587.
4. Cribb, A. E., S. P. Spielberg & G. P. Griffin: N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab. Dispos. 1995, 23, 406-414.
5. George, J., M. Murray, K. Byth & G. C. Farrell: Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 1995, 21, 120-128.
6. Guengerich, F. P.: Human cytochrome P-450 enzymes. Life Sci. 1992, 50, 1471-1478.
7. Hutterer, F., H. Denk, P. G. Bacchin, et al.: Mechanism of cholestasis. 1. Effect of bile acids on microsomal cytochrome P450 dependent biotransformation system in vitro. Life Sci. 1970, 9, 877-887.
8. Ioannides, C.: Cytochromes P450: metabolic and toxicological aspects. Boca Raton, CRC Press Inc., 1996.
9. Ishak, K. G. & R. S. Markin: Liver. In: Anderson's Pathology, 10th ed. Eds.: I Damjanov & J. Linder. St. Louis, Mosby-Year Book, Inc., 1996, pp. 1779-1858.
10. Kountouras, J., B. H. Billing & P. J. Scheuer: Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Brit. J. Exp. Path. 1984, 65, 305-311.
11. Lowry, O. H., N. J., Rosebrough, A. L., Farr, et al.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
12. McLean, A. J. & D. J. Morgan: Clinical pharmacokinetics in patients with liver disease. Clin. Pharmacokin. 1991, 21, 42-69.
13. 4-induced chronic liver damage. Biochem. Pharmacol. 1987, 36, 3021-3025.
14. Murray, M., L. Zaluzny & G. C. Farrell: Drug metabolism in cirrhosis. Selective changes in cytochrome P-450 isozymes in the choline-deficient rat model. Biochem. Pharmacol. 1986, 35, 1817-1824.
15. Murray, M., L. Zaluzny & G. C. Farrell: Impaired androgen 16α-hydroxylation in hepatic microsomes from carbon tetrachloride-cirrhotic male rats. Gastroenterology 1987, 93, 141-147.
16. Niwa, T., H. Kaneko, Y. Naritomi, et al.: Species and sex differences of testosterone and nifedipine oxidation in liver microsomes of rat, dog and monkey. Xenobiotics 1995, 25, 1041-1049.
17. Omura, T. & R. Sato: The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 1964, 239, 2370-2378.
18. Paolini, M., R. Mesirca, L. Pozzetti, et al.: Molecular non-genetic biomarkers related to fenarimol cocaricinogenesis: organ-and sex-specific CYP induction in rat. Cancer Letters 1996, 101, 171-178
19. Peter, P., R. Böcker, P. H. Beaune, et al.: Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem. Res. Toxicol. 1990, 3, 566-573.